Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

NBY NovaBay Pharmaceuticals Inc New

0,08

-0,0007 (-0,87%)

Vor Marktöffnung

Zuletzt aktualisiert: 14:19:43

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more NovaBay Pharmaceuticals Charts.

NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more NovaBay Pharmaceuticals Charts.

News NovaBay Pharmaceuticals Inc New

NovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye Symptoms
Montag 13 Mai 2024 (1 Tag vor) • Business Wire

NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results
Donnerstag 9 Mai 2024 (5 Tage vor) • Business Wire

NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon
Dienstag 7 Mai 2024 (1 Woche vor) • Business Wire

NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024
Freitag 3 Mai 2024 (2 Wochen vor) • Business Wire

NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales
Montag 22 April 2024 (3 Wochen vor) • Business Wire

NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity
Samstag 20 April 2024 (4 Wochen vor) • Business Wire

NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
Mittwoch 17 April 2024 (4 Wochen vor) • Business Wire

NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
Dienstag 26 März 2024 (2 Monate vor) • Business Wire

NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
Montag 25 März 2024 (2 Monate vor) • Business Wire

NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023
Donnerstag 14 März 2024 (2 Monate vor) • Business Wire

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dienstag 6 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere NovaBay Pharmaceuticals Inc New News-Artikel

Deutsche Telekom (QX)

Deutsche Lufthansa

Euro vs US Dollar

Euro vs Sterling

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen